Loading organizations...
Loading organizations...
Molecular pathology platform for genetic mutation detection and discovery.
ArcherDX has raised $150.0M across 3 funding rounds.
ArcherDX has raised $150.0M in total across 3 funding rounds.
ArcherDX has raised $150.0M in total across 3 funding rounds.
ArcherDX's investors include Michael Altman, ArrowMark Partners, Boulder Ventures, Driehaus Capital Management, Longwood Fund, PBM Capital, Redmile Group, Sands Capital, Soleus Capital, Sam Chawla, Peierls Foundation, Kyle Lefkoff.
ArcherDX has raised $150.0M across 3 funding rounds. Most recently, it raised $55.0M Series C in December 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 17, 2019 | $55.0M Series C | Michael Altman | ArrowMark Partners, Boulder Ventures, Driehaus Capital Management, Longwood Fund, PBM Capital, Redmile Group, Sands Capital, Soleus Capital |
| May 15, 2019 | $60.0M Series B | Sam Chawla | Boulder Ventures, Longwood Fund, PBM Capital, Peierls Foundation |
| Mar 20, 2018 | $35.0M Series A | Kyle Lefkoff, PBM Capital | Longwood Fund, Peierls Foundation |